PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.54
ESG score 80-90% of EYEN's 64.40. Walter Schloss would scrutinize governance quality and regulatory exposure.
57.89
Environmental score 1.1-1.2x EYEN's 54.08. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
58.17
Social score below 80% of EYEN's 73.37. Jim Chanos would check for potential social license and litigation risks.
56.57
Governance score 80-90% of EYEN's 65.75. Walter Schloss would scrutinize management accountability and board independence.